Free Trial

Cadrenal Therapeutics (CVKD) Short Interest Ratio & Short Volume

Cadrenal Therapeutics logo
$14.99 +0.98 (+7.00%)
(As of 11/22/2024 ET)

Cadrenal Therapeutics Short Interest Data

Cadrenal Therapeutics (CVKD) has a short interest of 39,500 shares, representing 9.06% of the float (the number of shares available for trading by the public). This marks a 65.27% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 70,736 shares to cover all short positions.

Current Short Interest
39,500 shares
Previous Short Interest
23,900 shares
Change Vs. Previous Month
+65.27%
Dollar Volume Sold Short
$669,920.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
1,660,000 shares
Float Size
435,900 shares
Short Percent of Float
9.06%
Today's Trading Volume
113,005 shares
Average Trading Volume
70,736 shares
Today's Volume Vs. Average
160%
Short Selling Cadrenal Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cadrenal Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CVKD Short Interest Over Time

CVKD Days to Cover Over Time

CVKD Percentage of Float Shorted Over Time

Cadrenal Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202439,500 shares $669,920.00 +65.3%9.1%0.7 $16.96
10/15/202423,900 shares $346,550.00 +32.8%5.5%0.5 $14.50
9/30/202418,000 shares $245,700.00 -7.2%3.2%0.6 $13.65
9/15/202419,400 shares $198,074.00 +22.8%3.4%0.8 $10.21
8/31/202415,800 shares $120,317.00 +295.0%2.8%0.8 $7.62
8/15/20244,000 shares $2,016.00 -91.8%0.7%0.2 $0.50
7/31/202449,000 shares $21,270.90 +67.2%0.6%0.4 $0.43
7/15/202429,300 shares $13,480.93 -41.5%0.3%0.3 $0.46
6/30/202450,100 shares $23,547.00 +18.7%0.6%0.2 $0.47
6/15/202442,200 shares $20,260.22 +478.1%0.5%0.2 $0.48
5/31/20247,300 shares $3,440.49 -27.0%0.1%0 $0.47
5/15/202410,000 shares $4,434.00 -85.4%0.1%0 $0.44
4/30/202468,500 shares $30,140.00 -60.6%0.8%0.2 $0.44
4/15/2024173,700 shares $70,348.50 +313.6%2.0%0.4 $0.41
3/31/202442,000 shares $25,620.00 +91.8%0.5%0.1 $0.61
3/15/202421,900 shares $12,877.20 +204.2%0.4%0.1 $0.59
2/29/20247,200 shares $5,068.80 -69.8%0.1%0 $0.70
2/15/202423,800 shares $18,566.38 -87.9%0.4%0.1 $0.78
1/31/2024196,700 shares $357,994.00 +389.3%3.6%0.6 $1.82
1/15/202440,200 shares $30,109.80 -38.7%0.7%0.3 $0.75
12/31/202365,600 shares $48,537.37 +28.9%1.2%0.9 $0.74
12/15/202350,900 shares $25,959.00 +50.6%0.9%0.9 $0.51
11/30/202333,800 shares $15,548.00 +38.5%0.6%0.9 $0.46
11/15/202324,400 shares $11,948.68 +101.7%0.5%0.5 $0.49
10/31/202312,100 shares $5,372.40 -63.4%0.3%0.2 $0.44
10/15/202333,100 shares $20,525.31 +126.7%0.7%0.5 $0.62
9/30/202314,600 shares $9,929.46 +1.4%0.3%0 $0.68
9/15/202314,400 shares $11,520.00 +65.5%0.3%0 $0.80
8/31/20238,700 shares $6,699.00 -82.3%0.2%0 $0.77
8/15/202349,100 shares $37,266.85 +16.4%1.2%0.1 $0.76
7/31/202342,200 shares $35,870.00 -90.2%1.4%0.1 $0.85
7/15/2023430,800 shares $555,688.92 +491.0%14.6%1.1 $1.29
6/30/202372,900 shares $110,079.00 +9.3%2.5%0.2 $1.51
6/15/202366,700 shares $101,384.00 -3.8%2.3%2.1 $1.52
5/31/202369,300 shares $98,406.00 -14.7%2.4%1.8 $1.42
5/15/202381,200 shares $114,492.00 No Change2.8%1.8 $1.41

CVKD Short Interest - Frequently Asked Questions

What is Cadrenal Therapeutics' current short interest?

Short interest is the volume of Cadrenal Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 39,500 shares of CVKD short. 9.06% of Cadrenal Therapeutics' shares are currently sold short. Learn More on Cadrenal Therapeutics' current short interest.

What is a good short interest ratio for Cadrenal Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CVKD shares currently have a short interest ratio of 1.0. Learn More on Cadrenal Therapeutics's short interest ratio.

What is a good short interest percentage for Cadrenal Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.06% of Cadrenal Therapeutics' floating shares are currently sold short.

Is Cadrenal Therapeutics' short interest increasing or decreasing?

Cadrenal Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 39,500 shares, an increase of 65.3% from the previous total of 23,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cadrenal Therapeutics' float size?

Cadrenal Therapeutics currently has issued a total of 1,660,000 shares. Some of Cadrenal Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cadrenal Therapeutics currently has a public float of 435,900 shares.

How does Cadrenal Therapeutics' short interest compare to its competitors?

9.06% of Cadrenal Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cadrenal Therapeutics: Assertio Holdings, Inc. (6.38%), Eupraxia Pharmaceuticals Inc. (0.39%), Quince Therapeutics, Inc. (7.33%), Cabaletta Bio, Inc. (7.59%), PowerUp Acquisition Corp. (0.06%), Generation Bio Co. (3.40%), Genenta Science S.p.A. (0.03%), SELLAS Life Sciences Group, Inc. (12.23%), Genelux Co. (5.15%), Invivyd, Inc. (11.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Cadrenal Therapeutics stock?

Short selling CVKD is an investing strategy that aims to generate trading profit from Cadrenal Therapeutics as its price is falling. CVKD shares are trading up $0.98 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cadrenal Therapeutics?

A short squeeze for Cadrenal Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CVKD, which in turn drives the price of the stock up even further.

How often is Cadrenal Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CVKD, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CVKD) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners